141 related articles for article (PubMed ID: 3563583)
21. The management of female hirsutism with the anti-androgen agent cyproterone.
Kwok PC; Correy JF; Senator GB
Asia Oceania J Obstet Gynaecol; 1985 Jun; 11(2):233-40. PubMed ID: 4038178
[No Abstract] [Full Text] [Related]
22. Diane 35 and spironolactone combination in the treatment of hirsutism.
Kelestimur F
Clin Endocrinol (Oxf); 2001 May; 54(5):699-700. PubMed ID: 11380503
[No Abstract] [Full Text] [Related]
23. Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial.
Alpañés M; Álvarez-Blasco F; Fernández-Durán E; Luque-Ramírez M; Escobar-Morreale HF
Eur J Endocrinol; 2017 Nov; 177(5):399-408. PubMed ID: 28912358
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
Sahin Y; Bayram F; Keleştimur F; Müderris I
J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
[TBL] [Abstract][Full Text] [Related]
25. 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Maier PS; Mattiello SS; Lages L; Spritzer PM
Gynecol Endocrinol; 2012 Aug; 28(8):606-10. PubMed ID: 22329763
[TBL] [Abstract][Full Text] [Related]
26. Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome.
Evans DJ; Burke CW
J R Soc Med; 1986 Aug; 79(8):451-3. PubMed ID: 3761287
[TBL] [Abstract][Full Text] [Related]
27. Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism.
Elkind-Hirsch KE; Anania C; Mack M; Malinak R
Fertil Steril; 1995 May; 63(5):970-8. PubMed ID: 7720941
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
Zemtsov A; Wilson L
Arch Dermatol; 1997 Apr; 133(4):431-3. PubMed ID: 9126004
[No Abstract] [Full Text] [Related]
29. Cyproterone acetate in the treatment of hirsutism.
Ylöstalo P; Laakso L; Viinikka L; Ylikorkala O; Vihko R
Acta Obstet Gynecol Scand; 1981; 60(4):399-401. PubMed ID: 7282307
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Inal MM; Yildirim Y; Taner CE
Fertil Steril; 2005 Dec; 84(6):1693-7. PubMed ID: 16359967
[TBL] [Abstract][Full Text] [Related]
31. An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism.
Anderson JA
Br J Dermatol; 1978 Nov; 99(5):545-52. PubMed ID: 708628
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of hirsutism and acne. Sequential inverse therapy with anti-androgen-estrogen].
Lebeau M; Vokaer R
J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):715-21. PubMed ID: 4267704
[No Abstract] [Full Text] [Related]
33. Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.
Rowan JP; Simon JA; Speroff L; Ellman H
Clin Ther; 2006 Jun; 28(6):921-32. PubMed ID: 16860174
[TBL] [Abstract][Full Text] [Related]
34. Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.
Harmanci A; Cinar N; Bayraktar M; Yildiz BO
Clin Endocrinol (Oxf); 2013 Jan; 78(1):120-5. PubMed ID: 22702394
[TBL] [Abstract][Full Text] [Related]
35. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
Daane TA; Dignam WJ; Frankland MV; Simmer HH; Parlow AF
Am J Obstet Gynecol; 1973 Oct; 117(3):392-9. PubMed ID: 4729733
[TBL] [Abstract][Full Text] [Related]
36. [A continuous experience of the use of norethindrone-ethinyl estradiol combination in small doses as a contraceptive].
Ruíz Moreno JA; Rubio Lotvin B; Bolio Arista R; de Larios NM
Ginecol Obstet Mex; 1977 Feb; 41(244):179-84. PubMed ID: 321297
[TBL] [Abstract][Full Text] [Related]
37. Spironolactone therapy in hirsutism and acne.
Callan AW
Australas J Dermatol; 1988; 29(3):135-9. PubMed ID: 2978784
[No Abstract] [Full Text] [Related]
38. [Anti-androgen treatment of hirsutism with cyproterone acetate].
Kása M; Egyedi K; Raffai S; Török L
Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
[TBL] [Abstract][Full Text] [Related]
39. Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism.
Kirschner MA; Samojlik E; Szmal E
J Clin Endocrinol Metab; 1987 Oct; 65(4):597-601. PubMed ID: 3654909
[TBL] [Abstract][Full Text] [Related]
40. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
Kelekci KH; Kelekci S; Yengel I; Gul S; Yilmaz B
J Dermatolog Treat; 2012 Jun; 23(3):177-83. PubMed ID: 21254871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
